An adaptive design is a useful clinical trial design tool which allowed identification of the optimal dose of NCX 470 in the Mont Blanc trial, the first Phase 3 trial of NCX 470 Both doses of NCX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback